Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 02.03. FARMACOS ANTIHIPERTENSIVOS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Others observations: Methyldopa is listed for use in the management of pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines. |
| Peru | 12.3 Anti-Hypertensives | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Cvs Hypotensive Agents-Miscellaneous | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 08. Antihipertensivos | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 1.4.2 Centrally Acting Alpha-Agonist | No observations |
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 50 TABLETAS |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 03. CARDIOLOGIA | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 03. CARDIOLOGIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 11.03. ANTIHIPERTENSIVOS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 15.02.01. Antiadrenergics- centrally acting- To be used in the Management of Pregnancy Induced Hypertension | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 24:08 Anti-hypertensive agents | No observations |
| Suriname. NGK-C-011 | 12.3 Antihypertensives | No observations |
| Haiti. National List of Essential Medicines | 12.03 Anti-hypertensives |
Others observations: Only for treatment of pregnancy-induced hypertension |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.08.16 Central Alpha Antagonist | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| Belize. National Drug Formulary | 12.03 Antihypertensive medicines | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.05.02 Centrally Acting Antihypertensive Drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 08. Antihipertensivos | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 1.4.2 Centrally Acting Alpha-Agonist | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 02. ANTIHIPERTENSIVOS | No observations |
| El Salvador - 2019 | ANTIHIPERTENSIVOS | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 24:08 Anti-hypertensive agents | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.08.16 Central Alpha Antagonist | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.05.02 Centrally Acting Antihypertensive Drugs | No observations |